Finance

Lists
Q3 2026 earnings • released • Revenue beat +1.54%
See results
LNA:EPA
LNA Sante SA
€26.40
+4.35%
(+1.10) 1D
Nov 6, 5:35:03 PM GMT+1  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for LNA...
Open
€25.20
High
€26.40
Low
€24.80
Mkt. cap
270.95M
Avg. vol.
9.58K
Volume
7.36K
P/E ratio
10.71
52-wk high
€36.50
52-wk low
€22.00
EPS
€2.47
Shares outstanding
10.71M
No. of employees
9K
Open
€25.20
High
€26.40
Low
€24.80
Mkt. cap
270.95M
Avg. vol.
9.58K
Volume
7.36K
P/E ratio
10.71
52-wk high
€36.50
52-wk low
€22.00
EPS
€2.47
Shares outstanding
10.71M
No. of employees
9K
News stories
From web sources and news partners
About LNA Sante SA
CEO-
Employees8.78K
Founded1990
Headquarters-
SectorHealth Care
IndustryHealth care provider
Last report
Nov 5, 2026
Fiscal period
Q3 2026
- / -
Revenue / Est. (EUR)
237.60M / 234.00M
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
-
Operating expense
-
-
-
-
Total operating expenses
-
-
-
-
Operating income
-
-
-
-
Other non operating income
-
-
-
-
EBT including unusual items
-
-
-
-
EBT excluding unusual items
-
-
-
-
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-
-
-
-
Net profit margin
2.75%
2.75%
2.58%
2.58%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps